{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:28:54Z","timestamp":1772508534907,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00125-010-1829-2","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T20:58:44Z","timestamp":1277931524000},"page":"2198-2204","source":"Crossref","is-referenced-by-count":40,"title":["Intradermal \u03b11-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease"],"prefix":"10.1007","volume":"53","author":[{"given":"H.","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Campbell-Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wasserfall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Brantly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"key":"1829_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","volume":"358","author":"MA Atkinson","year":"2001","unstructured":"Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221\u2013229","journal-title":"Lancet"},{"key":"1829_CR2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1464-5491.2008.02556.x","volume":"25","author":"S Cernea","year":"2008","unstructured":"Cernea S, Pozzilli P (2008) New potential treatments for protection of pancreatic B cell function in type 1 diabetes. Diabet Med 25:1259\u20131267","journal-title":"Diabet Med"},{"key":"1829_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.addr.2007.08.032","volume":"60","author":"L Pasquali","year":"2008","unstructured":"Pasquali L, Giannoukakis N, Trucco M (2008) Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetes. Adv Drug Deliv Rev 60:106\u2013113","journal-title":"Adv Drug Deliv Rev"},{"key":"1829_CR4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/db09-0557","volume":"58","author":"MJ Parker","year":"2009","unstructured":"Parker MJ, Xue S, Alexander JJ et al (2009) Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes 58:2277\u20132284","journal-title":"Diabetes"},{"key":"1829_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.gt.3302156","volume":"11","author":"S Song","year":"2004","unstructured":"Song S, Goudy K, Campbell-Thompson M et al (2004) Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther 11:181\u2013186","journal-title":"Gene Ther"},{"key":"1829_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/hum.2006.17.625","volume":"17","author":"Y Lu","year":"2006","unstructured":"Lu Y, Tang M, Wasserfall C et al (2006) Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum Gene Ther 17:625\u2013634","journal-title":"Hum Gene Ther"},{"key":"1829_CR7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/db06-1273","volume":"56","author":"B Zhang","year":"2007","unstructured":"Zhang B, Lu Y, Campbell-Thompson M et al (2007) Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 56:1316\u20131323","journal-title":"Diabetes"},{"key":"1829_CR8","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1073\/pnas.0505579102","volume":"102","author":"EC Lewis","year":"2005","unstructured":"Lewis EC, Shapiro L, Bowers OJ, Dinarello CA (2005) Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci U S A 102:12153\u201312158","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1829_CR9","doi-asserted-by":"crossref","first-page":"16236","DOI":"10.1073\/pnas.0807627105","volume":"105","author":"EC Lewis","year":"2008","unstructured":"Lewis EC, Mizrahi M, Toledano M et al (2008) Alpha1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A 105:16236\u201316241","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1829_CR10","doi-asserted-by":"crossref","first-page":"16242","DOI":"10.1073\/pnas.0808031105","volume":"105","author":"M Koulmanda","year":"2008","unstructured":"Koulmanda M, Bhasin M, Hoffman L et al (2008) Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 105:16242\u201316247","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1829_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2249.2008.03721.x","volume":"154","author":"Y Lu","year":"2008","unstructured":"Lu Y, Parker M, Pileggi A et al (2008) Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice. Clin Exp Immunol 154:15\u201321","journal-title":"Clin Exp Immunol"},{"key":"1829_CR12","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/01.tp.0000269611.66517.bf","volume":"84","author":"S Rutella","year":"2007","unstructured":"Rutella S (2007) Granulocyte colony-stimulating factor for the induction of T cell tolerance. Transplantation 84:S26\u201330","journal-title":"Transplantation"},{"key":"1829_CR13","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1182\/blood.V85.9.2482.bloodjournal8592482","volume":"85","author":"T Hartung","year":"1995","unstructured":"Hartung T, Docke WD, Gantner F et al (1995) Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482\u20132489","journal-title":"Blood"},{"key":"1829_CR14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/eji.200324651","volume":"34","author":"S Rutella","year":"2004","unstructured":"Rutella S, Bonanno G, Pierelli L et al (2004) Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 34:1291\u20131302","journal-title":"Eur J Immunol"},{"key":"1829_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2337\/diabetes.54.1.78","volume":"54","author":"H Kared","year":"2005","unstructured":"Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F (2005) Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+ CD25+ regulatory T cells. Diabetes 54:78\u201384","journal-title":"Diabetes"},{"key":"1829_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaut.2005.01.001","volume":"24","author":"K Hadaya","year":"2005","unstructured":"Hadaya K, Kared H, Masson A, Chatenoud L, Zavala F (2005) G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse. J Autoimmun 24:125\u2013134","journal-title":"J Autoimmun"},{"key":"1829_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1073\/pnas.0809999106","volume":"106","author":"Y Lu","year":"2009","unstructured":"Lu Y, Song S (2009) Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors. Proc Natl Acad Sci U S A 106:5","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1829_CR18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaci.2007.07.033","volume":"120","author":"FD Finkelman","year":"2007","unstructured":"Finkelman FD (2007) Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 120:506\u2013515, quiz 516\u2013507","journal-title":"J Allergy Clin Immunol"},{"key":"1829_CR19","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1074\/jbc.M607976200","volume":"282","author":"SM Janciauskiene","year":"2007","unstructured":"Janciauskiene SM, Nita IM, Stevens T (2007) Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem 282:8573\u20138582","journal-title":"J Biol Chem"},{"key":"1829_CR20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jgm.1409","volume":"12","author":"C Grimstein","year":"2010","unstructured":"Grimstein C, Choi Y-K, Satoh M et al (2010) Combination of alpha-1 antitrypsin and doxycycline suppresses collagen induced arthritis. J Gene Med 12:35\u201344","journal-title":"J Gene Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-010-1829-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-010-1829-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-010-1829-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T22:27:02Z","timestamp":1711578422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-010-1829-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1007\/s00125-010-1829-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}